Serina Therapeutics, Inc.SERNYSE
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank78
5Y CAGR+258.4%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+258.4%/yr
Long-term compound
Percentile
P78
Within normal range
vs 5Y Ago
591.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.73M | -19.0% |
| 2024 | $5.84M | -30.4% |
| 2023 | $8.40M | +2139.6% |
| 2022 | $-411740.00 | -212.3% |
| 2021 | $366805.00 | +4485.1% |
| 2020 | $8000.00 | -97.5% |
| 2019 | $323000.00 | -88.1% |
| 2018 | $2.71M | +52.5% |
| 2017 | $1.78M | +138.6% |
| 2016 | $-4.62M | - |